Ozempic Alternatives: Compounded Semaglutide from $149/mo

Brand-name Ozempic costs between $900 and $1,400+ per month without insurance, making it one of the most expensive weight loss treatments available. For many patients, that cost is simply unsustainable for a medication that requires long-term use.

Persistent supply shortages have made the situation even more difficult. Even patients with valid prescriptions have faced weeks or months without access to their medication, disrupting treatment plans and weight loss progress.

Insurance coverage for GLP-1 medications remains inconsistent. Many plans exclude weight loss indications entirely, while others require lengthy prior authorization processes that can delay treatment by weeks. Patients often discover their coverage is denied only after their provider has already prescribed the medication.

These cost barriers make it difficult for patients to stay on treatment long enough to see meaningful results. That is why many people are turning to compounded semaglutide as an affordable, accessible alternative.

Compounded semaglutide contains the same active ingredient as brand-name Ozempic. The difference is how it is produced: instead of being manufactured by Novo Nordisk, it is prepared by US-licensed compounding pharmacies that customize medications based on individual prescriptions.

These compounding pharmacies are regulated and routinely inspected to ensure quality and safety standards. They operate under federal and state oversight, following strict protocols for medication preparation.

One advantage of compounded semaglutide is formulation flexibility. While brand Ozempic is available only as an injectable, compounded versions may be available in both injectable and oral forms, giving patients and providers more options for treatment. Learn more in our compounded semaglutide guide.

Compounded semaglutide contains the same active ingredient as brand-name Ozempic: semaglutide. Because the active molecule is identical, the mechanism of action is the same. Semaglutide works by mimicking GLP-1, a hormone that regulates appetite and blood sugar, helping reduce food intake and promote weight loss.

It is important to note that compounded medications are not FDA-approved products. However, they are prepared under FDA-regulated conditions by licensed pharmacies that follow strict compounding standards. The active ingredient itself is the same compound used in FDA-approved semaglutide medications.

Individual results may vary based on dosage, adherence, diet, exercise, and other health factors. Your prescribing provider will monitor your progress and adjust treatment as needed.

Tirzepatide is a dual GIP/GLP-1 receptor agonist that targets two hormones instead of one. Clinical studies suggest it may offer greater weight loss compared to semaglutide alone, making it an increasingly popular option for patients seeking more aggressive treatment.

Tirzepatide is also available through VivioMD starting at $149/mo. For a detailed comparison of these two medications, including mechanism of action, clinical results, and side effects, see our semaglutide vs tirzepatide comparison.